What is the address of Dr. Jane Dewingaerden, Huisarts?

The registered office of Dr. Jane Dewingaerden, Huisarts is located at Boskantweg 2, 1820 Steenokkerzeel.

Is Dr. Jane Dewingaerden, Huisarts still active?

Yes. According to the CBE (17 September 2026) Dr. Jane Dewingaerden, Huisarts is active, legal situation “Normale toestand”, started on 9 December 2021.

Is Dr. Jane Dewingaerden, Huisarts registered on Peppol?

Yes, Dr. Jane Dewingaerden, Huisarts is registered on the Peppol network with ID 0208:0778430641.

What is the enterprise number of Dr. Jane Dewingaerden, Huisarts?

The enterprise number of Dr. Jane Dewingaerden, Huisarts is BE0778430641.

When was Dr. Jane Dewingaerden, Huisarts founded?

Dr. Jane Dewingaerden, Huisarts was founded on 9 December 2021.

Who are the directors of Dr. Jane Dewingaerden, Huisarts?

According to the 2025 annual accounts, the directors of Dr. Jane Dewingaerden, Huisarts are: Jane Dewingaerden.

Is Dr. Jane Dewingaerden, Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Jane Dewingaerden, Huisarts make in 2025?

Dr. Jane Dewingaerden, Huisarts posted a profit after taxes of € 86,254 in financial year 2025.

What is the revenue of Dr. Jane Dewingaerden, Huisarts?

As a small company, Dr. Jane Dewingaerden, Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 109,406.

Dr. Jane Dewingaerden, Huisarts (Private Limited)

Dossier Dr. Jane Dewingaerden, Huisarts, printed on 17 September 2026 from databakkes.be/en/0778430641/dr-jane-dewingaerden-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Jane Dewingaerden, Huisarts from Steenokkerzeel, company number BE0778430641, closed financial year 2025 with a result of € 86,254 after tax. For that financial year Dr. Jane Dewingaerden, Huisarts recorded a gross margin of € 109,406 and equity of € 2,000. Compared with financial year 2024, the result moved from € 84,403 to € 86,254. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Shrank hard

€ 2,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,254

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 62,171

▼ 54% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 350,088 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,741

▲ 117% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,150

▼ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,090 Gross margin 2022: € 125,090 First fiscal year in the series	€ 110,217 Gross margin 2023: € 110,217 ▼ 12% vs 2022 (€ 125,090) Unfavourable step	€ 108,038 Gross margin 2024: € 108,038 ▼ 2% vs 2023 (€ 110,217) Unfavourable step	€ 109,406 Gross margin 2025: € 109,406 ▲ 1% vs 2024 (€ 108,038) Favourable step	▲ 1%
Profit after taxes	€ 95,921 Profit after taxes 2022: € 95,921 First fiscal year in the series	€ 83,510 Profit after taxes 2023: € 83,510 ▼ 13% vs 2022 (€ 95,921) Unfavourable step	€ 84,403 Profit after taxes 2024: € 84,403 ▲ 1% vs 2023 (€ 83,510) Favourable step	€ 86,254 Profit after taxes 2025: € 86,254 ▲ 2% vs 2024 (€ 84,403) Favourable step	▲ 2%
Equity	€ 97,921 Equity 2022: € 97,921 First fiscal year in the series	€ 181,431 Equity 2023: € 181,431 ▲ 85% vs 2022 (€ 97,921) Favourable step	€ 265,834 Equity 2024: € 265,834 ▲ 47% vs 2023 (€ 181,431) Favourable step	€ 2,000 Equity 2025: € 2,000 ▼ 99% vs 2024 (€ 265,834) Unfavourable step	▼ 99%
Total debts	€ 36,657 Total debts 2022: € 36,657 First fiscal year in the series	€ 35,354 Total debts 2023: € 35,354 ▼ 4% vs 2022 (€ 36,657) Favourable step	€ 28,703 Total debts 2024: € 28,703 ▼ 19% vs 2023 (€ 35,354) Favourable step	€ 118,971 Total debts 2025: € 118,971 ▲ € 90,268 vs 2024 (€ 28,703) Unfavourable step	▲ € 90,268
Cash	€ 128,300 Cash 2022: € 128,300 First fiscal year in the series	€ 56,065 Cash 2023: € 56,065 ▼ 56% vs 2022 (€ 128,300) Unfavourable step	€ 134,880 Cash 2024: € 134,880 ▲ 141% vs 2023 (€ 56,065) Favourable step	€ 62,171 Cash 2025: € 62,171 ▼ 54% vs 2024 (€ 134,880) Unfavourable step	▼ 54%
Retained profit	€ 95,921 Retained profit 2022: € 95,921 First fiscal year in the series	€ 179,431 Retained profit 2023: € 179,431 ▲ 87% vs 2022 (€ 95,921) Favourable step	€ 263,834 Retained profit 2024: € 263,834 ▲ 47% vs 2023 (€ 179,431) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 263,834) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 350,088 Dividend 2025: € 350,088 Unchanged (€ 0) Unchanged
Balance sheet total	€ 134,578 Balance sheet total 2022: € 134,578 First fiscal year in the series	€ 216,786 Balance sheet total 2023: € 216,786 ▲ 61% vs 2022 (€ 134,578) Unchanged	€ 294,537 Balance sheet total 2024: € 294,537 ▲ 36% vs 2023 (€ 216,786) Unchanged	€ 120,971 Balance sheet total 2025: € 120,971 ▼ 59% vs 2024 (€ 294,537) Unchanged	▼ 59%

Key figures of Dr. Jane Dewingaerden, Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Jane Dewingaerden, Huisarts?

What happened at Dr. Jane Dewingaerden, Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 86,254 (▲ 2% vs 2024). Source: NBB ↗
Dec 9, 2021 New establishment in Steenokkerzeel. KBO
2021 Jane Dewingaerden became a director. NBB
Dec 9, 2021 Start of the company according to the CBE. KBO

In short

From € 95,921 profit in 2022 to € 86,254 profit in 2025.

Paid € 100,315 in corporate taxes since 2022.

Best year ever: 2022, with € 95,921 profit.

Paid out € 350,088 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Jane Dewingaerden, Huisarts? We notify you, reason included.

Follow Dr. Jane Dewingaerden, Huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jane Dewingaerden

Dr. Jane Dewingaerden, Huisarts

Behind Dr. Jane Dewingaerden, Huisarts is Jane Dewingaerden.

See the full network in the app

Directors

According to the 2025 annual accounts

Jane Dewingaerden

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Boskantweg 2

1820 Steenokkerzeel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0778.430.641
VAT number: BE 0778.430.641
Registered office: Boskantweg 2, 1820 Steenokkerzeel
Names & denominations: Dr. Jane Dewingaerden, Huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 December 2021
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗